Machine learning approaches to drug response prediction: challenges and recent progress
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning approaches to drug response prediction: challenges and recent progress
Authors
Keywords
-
Journal
npj Precision Oncology
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-15
DOI
10.1038/s41698-020-0122-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Dr.VAE: Improving drug response prediction via modeling of drug perturbation effects
- (2019) Ladislav Rampášek et al. BIOINFORMATICS
- Correction to: Predicting drug response of tumors from integrated genomic profiles by deep neural networks
- (2019) Yu-Chiao Chiu et al. BMC Medical Genomics
- Kernelized rank learning for personalized drug recommendation
- (2018) Xiao He et al. BIOINFORMATICS
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2018) John Heymach et al. JOURNAL OF CLINICAL ONCOLOGY
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens
- (2018) Alexander Ling et al. PHARMACOLOGY & THERAPEUTICS
- DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity
- (2018) Benedict Anchang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia
- (2018) Su-In Lee et al. Nature Communications
- Interpretable dimensionality reduction of single cell transcriptome data with deep generative models
- (2018) Jiarui Ding et al. Nature Communications
- Cancer Drug Response Profile scan (CDRscan): A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature
- (2018) Yoosup Chang et al. Scientific Reports
- A novel heterogeneous network-based method for drug response prediction in cancer cell lines
- (2018) Fei Zhang et al. Scientific Reports
- Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
- (2018) Rafael Gómez-Bombarelli et al. ACS Central Science
- Cancer Drugs Approved Based on Biomarkers and Not Tumor Type—FDA Approval of Pembrolizumab for Mismatch Repair-Deficient Solid Cancers
- (2018) Vinay Prasad et al. JAMA Oncology
- Deep learning in omics: a survey and guideline
- (2018) Zhiqiang Zhang et al. Briefings in Functional Genomics
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
- (2018) Jin-Ku Lee et al. NATURE GENETICS
- clusterExperiment and RSEC: A Bioconductor package and framework for clustering of single-cell and other large gene expression datasets
- (2018) Davide Risso et al. PLoS Computational Biology
- Precision Oncology beyond Targeted Therapy: Combining Omics Data with Machine Learning Matches the Majority of Cancer Cells to Effective Therapeutics
- (2017) Michael Q. Ding et al. MOLECULAR CANCER RESEARCH
- Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
- (2017) Huipeng Li et al. NATURE GENETICS
- Rationalizing combination therapies
- (2017) NATURE MEDICINE
- PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies
- (2017) Petr Smirnov et al. NUCLEIC ACIDS RESEARCH
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Gene isoforms as expression-based biomarkers predictive of drug response in vitro
- (2017) Zhaleh Safikhani et al. Nature Communications
- Advances in single-cell RNA sequencing and its applications in cancer research
- (2017) Sibo Zhu et al. Oncotarget
- A Computational Approach for Identifying Synergistic Drug Combinations
- (2017) Kaitlyn M. Gayvert et al. PLoS Computational Biology
- Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways
- (2016) M. Doherty et al. ANNALS OF ONCOLOGY
- A Landscape of Pharmacogenomic Interactions in Cancer
- (2016) Francesco Iorio et al. CELL
- Drug combination therapy increases successful drug repositioning
- (2016) Wei Sun et al. DRUG DISCOVERY TODAY
- Molecular graph convolutions: moving beyond fingerprints
- (2016) Steven Kearnes et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies
- (2016) Jennifer O'Neil et al. MOLECULAR CANCER THERAPEUTICS
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data
- (2016) Alexander Aliper et al. MOLECULAR PHARMACEUTICS
- Reproducible pharmacogenomic profiling of cancer cell line panels
- (2016) Peter M. Haverty et al. NATURE
- Clonal genotype and population structure inference from single-cell tumor sequencing
- (2016) Andrew Roth et al. NATURE METHODS
- Optimization of drug combinations using Feedback System Control
- (2016) Patrycja Nowak-Sliwinska et al. Nature Protocols
- Assessing intratumor heterogeneity and tracking longitudinal and spatial clonal evolutionary history by next-generation sequencing
- (2016) Yuchao Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures
- (2016) Mohammed El-Kebir et al. Cell Systems
- Prioritization of anticancer drugs against a cancer using genomic features of cancer cells: A step towards personalized medicine
- (2016) Sudheer Gupta et al. Scientific Reports
- Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
- (2015) Xiao-xiao Sun et al. ACTA PHARMACOLOGICA SINICA
- Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer
- (2015) Andrea Weiss et al. ANGIOGENESIS
- PharmacoGx: an R package for analysis of large pharmacogenomic datasets
- (2015) Petr Smirnov et al. BIOINFORMATICS
- The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform
- (2015) Amber Johnson et al. DRUG DISCOVERY TODAY
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
- (2015) Hui Gao et al. NATURE MEDICINE
- Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment
- (2015) Ayako Suzuki et al. GENOME BIOLOGY
- PhyloWGS: Reconstructing subclonal composition and evolution from whole-genome sequencing of tumors
- (2015) Amit G Deshwar et al. GENOME BIOLOGY
- Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data
- (2014) Layla Oesper et al. BIOINFORMATICS
- Drug susceptibility prediction against a panel of drugs using kernelized Bayesian multitask learning
- (2014) Mehmet Gönen et al. BIOINFORMATICS
- Computational identification of multi-omic correlates of anticancer therapeutic response
- (2014) Lindsay C Stetson et al. BMC GENOMICS
- Enhancing Reproducibility in Cancer Drug Screening: How Do We Move Forward?
- (2014) C. Hatzis et al. CANCER RESEARCH
- The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
- (2014) Terri Patricia McVeigh et al. EUROPEAN JOURNAL OF CANCER
- A community effort to assess and improve drug sensitivity prediction algorithms
- (2014) James C Costello et al. NATURE BIOTECHNOLOGY
- PyClone: statistical inference of clonal population structure in cancer
- (2014) Andrew Roth et al. NATURE METHODS
- DCDB 2.0: a major update of the drug combination database
- (2014) Y. Liu et al. Database-The Journal of Biological Databases and Curation
- SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution
- (2014) Christopher A. Miller et al. PLoS Computational Biology
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- mRMRe: an R package for parallelized mRMR ensemble feature selection
- (2013) Nicolas De Jay et al. BIOINFORMATICS
- Precision Oncology: An Overview
- (2013) Levi A. Garraway et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison and validation of genomic predictors for anticancer drug sensitivity
- (2013) Simon Papillon-Cavanagh et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Machine Learning Prediction of Cancer Cell Sensitivity to Drugs Based on Genomic and Chemical Properties
- (2013) Michael P. Menden et al. PLoS One
- Targeting protein–protein interactions as an anticancer strategy
- (2013) Andrei A. Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- (2012) Mathew J. Garnett et al. NATURE
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
- (2009) Elzbieta A Slodkowska et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
- (2009) Jolien Tol et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
- (2008) J. Randolph Hecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
- (2008) Wataru Sakai et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search